Table 4.
Clinical characteristics at baseline of patients with and without clinical remission of the disease during follow-up
| Variablea | Patients with Remission (n=53) | Patients without Remission (n=88) | P Value |
|---|---|---|---|
| Age (years) | 21.6 (13.7) | 25 (15.4) | 0.20 |
| Males (%) | 73.6 | 59.1 | 0.08 |
| BMI (kg/m2) | 22.2 (4.3) | 21.9 (3.9) | 0.60 |
| Mean BP (mmHg) | 84.1 (15.3) | 87.5 (12.8) | 0.20 |
| SCr (mg/dl) | 0.8 (0.2) | 0.8 (0.2) | 0.80 |
| eGFR (ml/min per 1.73 m2) | 114.2 (32) | 110.3 (31.4) | 0.50 |
| Proteinuria (g/24 h) | 0.1 (0.1) | 0.3 (0.2) | <0.001 |
| ACEI/ARB treatment | 12 (22.6%) | 47 (53.4%) | <0.001 |
| Smokers | 4 (7.5%) | 18 (20.5%) | 0.04 |
| Follow-up (months) | 102 (52–156) | 120 (66–180) | 0.20 |
| M1 Oxford classification | 13 (24.5%) | 33 (37.5%) | 0.10 |
| E1 Oxford classification | 2 (3.8%) | 10 (11.4%) | 0.10 |
| S1 Oxford classification | 4 (7.5%) | 18 (20.5%) | 0.04 |
a
For quantitative variables, values are expressed as mean (SD) or mean (range). For qualitative variables, values are expressed as n (%).